# Three Induction Treatments on Cryptococcal Meningitis

> **NCT04072640** · EARLY_PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 120 (estimated)

## Conditions studied

- Cryptococcal Meningitis
- HIV/AIDS

## Interventions

- **DRUG:** Voriconazole 200mg
- **DRUG:** amphotericin B deoxycholate (0.4-0.5mg/kg/d)
- **DRUG:** Amphotericin B-deoxycholate (0.7-1.0mg/kg/d)

## Key facts

- **NCT ID:** NCT04072640
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-25
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-12-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072640, "Three Induction Treatments on Cryptococcal Meningitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04072640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*